Global Heparin Market Poised to Grow at a CAGR of 5.91% by 2023

Global Heparin Market Poised to Grow at a CAGR of 5.91% by 2023


Infinium Global Research has added a new report on Heparin Market. The report presents analysis of global as well as regional markets of heparin over the period of 2017 - 2023. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the Global heparin market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017 to 2023.   

 

Get 15% discount for early purchase of Global Heparin Market report by clicking the following link, Use code IGRD15 to request the discount in the given form           

https://www.infiniumglobalresearch.com/Reports/requestdiscount/120

               

The recent report identified that North America dominated the global heparin market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the heparin market worldwide.                

               

The report segments the global heparin market on the basis of by product type, by route of administration, by application, and by end user.


Global Heparin Market by Product Type              

                • Introduction

                • Low Molecular Weight Heparin

                • Unfractionated Heparin

                • Ultra-low Molecular Weight Heparin


Global Heparin Market by Route of Administration       

                • Introduction

                • IV injection

                • Subcutaneous injection


Global Heparin Market by Application

                • Introduction

                • Clinical trials

                • Medical devices

                • Disease treatment


Global Heparin Market by End User      

                • Introduction

                • Hospitals

                • Blood and Stem Cell Bank

                • Others


Global Heparin Market by Regions        

                • North America

                • Europe

                • Asia-Pacific

                • RoW


Companies Profiled in the report           

                • Sanofi SA

                • GlaxoSmithKline plc

                • Pfizer, Inc.

                • Leo Pharma

                • Dr. Reddy’s Laboratories

                • Fresenius SE & Co. KG

                • Teva Pharmaceutical Industries Ltd.

                • Baxter International

                • Aspen Holdings

                • Others


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement. 


© 2024. Infinium Global Research LLP. All Rights Reserved.